Finland· FI-REL-REL7220

Vioform

A clioquinol product, registered in Finland by Novartis Pharma Stein AG.

ATC D08AH30

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedVioformATCD08AH30REGISTER NO.FI-REL-REL7220PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
Novartis Pharma Stein AG
Country
Finland (FI)
ATC code
D08AH30
ATC class
Clioquinol
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for clioquinol.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Clioquinol · interactions on record

1 record

  • 1 severe

Most severe, free to view

  • VigabatrinN03AG04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under D08AH30

Clioquinol, as other registers publish it.

All clioquinol products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c312a4e2-9ff5-488f-ace1-be31111b1da1
GET /v1/drugs/c312a4e2-9ff5-488f-ace1-be31111b1da1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "emulsiovoide",
  "route": null,
  "ddd_unit": null,
  "strength": "3 %",
  "atc_label": "kliokinoli",
  "ma_number": "1391",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL7220",
  "authorised_at": "1965-05-05"
}

See everything about clioquinol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.